Explore FMI!
Book a free demo
As per Arthritis Care & Research,almost 20-50% of people suffering from ankylosing spondylitis are reported to show spinal progression of certain level in the last two years of follow-up.
The TNF inhibitor treatments and NSAIDs (Non-steroid anti-inflammatory drugs) have been cornerstone therapies regarding managing ankylosing spondylitis and other types of inflammatory arthritis conditions.
The European Congress of Rheumatology (EULAR) annual meeting presented a French study raising a concern that rheumatologists, in spite of being knowledgeable about biosimilars, abstain from switching over to them due to lack of confidence in this treatment option.
On the other hand, European Journal of Integrative Medicine, Sep 2019, stated that Moxibustion, a type of heat therapy combined with traditional treatments is likely to provide short-term benefit to the ones affected by ankylosing spondylitis. This therapy is already put into practice all over East Asia.
Besides, findings at the Universita Degli Studi del Molise (Italy) state that physiotherapy is advantageous for ankylosing spondylitis-affected patients.
Though anti-inteleukin medications and anti-tumor necrosis have improved prognosis for a sizable number of patients; physiotherapy helps those who do not respond positively to these drugs. Moreover, modern day treatments press for physical rehabilitation and therapy.
Of late, research conducted at the University of Medical Sciences (Iran) concluded that T reg cells (suppressing the immune system) were upregulated in ankylosing spondylitis-affected patients who received a dose of nanocurcumin for 4 months in a row. Turmeric contains curcumin in the form of a naturally-occurring yellow colored substance.
The factors mentioned above are expected to compel the governments to divert a greater portion of their revenue towards extensive research, thereby driving the ankylosing spondylitis treatment market.
The ankylosing spondylitis treatment market players are focusing on innovation and approval to gain a competitive edge over one another.
This trend is bound to help the ankylosing spondylitis market stand in a better stead between 2020 and 2030.
For instance –
The healthcare industry is moving towards extensive research with regards to ankylosing spondylitis, so as to continue with the geometric progression on the count of innovations.
For instance –
The ankylosing spondylitis treatment market players have been devising biosimilars to combat ankylosing spondylitis.
Also, branded drugs’ patent expiry is opening doors for biosimilars. For instance – Remicade expired in 2015. This resulted in Inflectra getting introduced in 2016. The year 2017 witnessed introduction of Renflexis. Likewise, in 2019, Avsola got introduced.
The major players in the ankylosing spondylitis treatment market include:
The ankylosing spondylitis treatment market, as stated by FMI, is expected to witness a steady growth rate between 2020 and 2030.
The market players are working on war footing to devise medications for ankylosing spondylitis.
Inorganic growth parameters could also be pondered about. For instance – strategic partnerships across various geographies could help in reaching out to more number of patients
The ankylosing spondylitis treatment market is likely to secure a CAGR of 4.6% through 2032.
The ankylosing spondylitis treatment market size is estimated to cross UD 5.1409 Billion by 2032.
The ankylosing spondylitis treatment market is likely to record a value of USD 8.06 Billion in 2022.
North America is likely to lead the ankylosing spondylitis treatment market.
Dental 3D Printing Material Market Trends, Growth & Forecast by Material, Product, and Region through 2035
Catheter Market Insights by Product, Indication, End-user, and Region 2025 to 2035
Healthcare Digital Experience Platform Market Trends - Growth & Forecast 2025 to 2035
Healthcare Interoperability Solutions Market Analysis – Trends & Growth 2025 to 2035
High-end Cellomics Market Analysis - Growth, Trends & Forecast 2025 to 2035
Headspace Gas Analyzers Market - Trends & Forecast 2025 to 2035
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.